Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01958346 · ClinicalTrials.gov registry record · NA
New Maneuver to Facilitate Fiberoptic Intubation for Difficult Airway
A NA study of Anticipated Difficult Airway, sponsored by Enrico Camporesi.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
- 1
- Study location
NCT01958346: Completed NA study of Anticipated Difficult Airway, sponsored by Enrico Camporesi.
NCT01958346 is a NA study of Anticipated Difficult Airway that has completed, run by Enrico Camporesi. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01958346, a NA study of Anticipated Difficult Airway, has completed, sponsored by Enrico Camporesi.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
We propose the additional technique of lingual traction or "tongue pulling" in conjunction with use of the flexible fiberoptic bronchoscope for facilitating successful first attempts at and decreasing time to intubation of the difficult airway and rescuing otherwise failed intubation attempts. Induction of general anesthesia causes relaxation and approximation of the soft palate, base of the tongue, epiglottis, and posterior pharyngeal wall, creating unfavorable anatomic changes in the pharynx for successful intubation. The use of lingual traction can assist in diminishing these problems by clearing the tongue away from the soft palate and uvula and lifting the epiglottis from the posterior pharyngeal wall, especially in the unanticipated difficult airway patient.
Conditions Studied
Interventions
- OTHER Sham
- OTHER Lingual Traction
- DEVICE Fiberoptic Intubation
Study Locations (1)
Florida
- Tampa General Hospital - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT01958346 record still lists
NCT01958346 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Anticipated Difficult Airway appearing as the primary indexed condition, and to 3 interventions - of which Sham is the first listed.
NCT01958346 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01958346 about?
NCT01958346 is a clinical study titled "New Maneuver to Facilitate Fiberoptic Intubation for Difficult Airway". We propose the additional technique of lingual traction or "tongue pulling" in conjunction with use of the flexible fiberoptic bronchoscope for facilitating successful first attempts at and decreasing time to intubation of the difficult airway and rescuing otherwise failed intubation attempts. Induc...
What is the current status of trial NCT01958346?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2012-06. Estimated completion is 2013-11.
What conditions does trial NCT01958346 study?
This clinical trial studies the following conditions: Anticipated Difficult Airway.
What interventions are being tested in trial NCT01958346?
The interventions under investigation include: Sham (OTHER), Lingual Traction (OTHER), Fiberoptic Intubation (DEVICE).
Who is sponsoring clinical trial NCT01958346?
This trial is sponsored by Enrico Camporesi, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01958346 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01958346's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia